Variable Responses to Tocilizumab in Four Patients with Schnitzler Syndrome

J Clin Immunol. 2019 May;39(4):370-372. doi: 10.1007/s10875-019-00644-1. Epub 2019 May 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Biomarkers
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Middle Aged
  • Schnitzler Syndrome / diagnosis
  • Schnitzler Syndrome / drug therapy*
  • Schnitzler Syndrome / etiology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • tocilizumab